Changes

==Concept Table==

| style="background-color:#99ccff;;padding:0.079cm;"| <center>'''S.No'''</center>

| style="background-color:#99ccff;;padding:0.079cm;"| <center>'''Concept-1'''</center>

|}

===French Keywords Concept table===

| style="background-color:#99ccff;;padding:0.079cm;"| <center>'''S.No'''</center>

| style="background-color:#99ccff;;padding:0.079cm;"| <center>'''Concept-1'''</center>

===German Keywords Concept Table===

| style="background-color:#99ccff;;padding:0.079cm;"| <center>'''S.No'''</center>

| style="background-color:#99ccff;;padding:0.079cm;"| <center>'''Concept-1'''</center>

* '''Relevant IPC classes'''

|align = "center" bgcolor = "#99CCFF" colspan = "4"|'''IPC'''

|-

|-

|align = "center"|A61K003819

|align = "center"|Medicinal preparations containing peptides - Cytokines; Lymphokines; Interferons

|align = "center"|Broad

|-

|align = "center"|A61K003821

|align = "center"|Medicinal preparations containing peptides Interferon

|align = "center"|Specific

|-

|align = "center"|C07K001452

|align = "center"|Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof - Cytokines; Lymphokines; Interferons

|align = "center"|Broad

|-

|align = "center"|C07K014555

|align = "center"|Peptides having more than 20 amino acids - Interferon

|align = "center"|Specific

|-

|align = "center"|C07K001456

|align = "center"|Peptides having more than 20 amino acids - IFN-alpha

|align = "center"|Specific

|-

|align = "center"|C07K014565

|align = "center"|Peptides having more than 20 amino acids - IFN-beta

|align = "center"|Specific

|-

|align = "center"|C07K001457

|align = "center"|Peptides having more than 20 amino acids - IFN-gamma

|align = "center"|Specific

|-

|align = "center"|A61P003500

|align = "center"|Therapeutic activity of chemical compounds or medicinal preparations -antineoplastic agents

* '''Relevant ECLA classes'''

|align = "center" bgcolor = "#99CCFF" colspan = "4"|'''ECLA'''

|-

|-

|align = "center"|A61K003819

|align = "center"|Medicinal preparations containing peptides - Cytokines; Lymphokines; Interferons

|align = "center"|Broad

|-

|align = "center"|A61K003821

|align = "center"|Medicinal preparations containing Interferon

|align = "center"|Specific

|-

|align = "center"|A61K38/21A

|align = "center"|Medicinal preparations containing IFN-alpha

|align = "center"|Specific

|-

|align = "center"|A61K38/21B

|align = "center"|Medicinal preparations containing IFN-beta

|align = "center"|Specific

|-

|align = "center"|A61K38/21C

|align = "center"|Medicinal preparations containing IFN-gamma

|align = "center"|Specific

|-

|align = "center"|C07K001452

|align = "center"|Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof - Cytokines; Lymphokines; Interferons

|align = "center"|Broad

|-

|align = "center"|C07K014555

|align = "center"|Peptides having more than 20 amino acids - Interferon

|align = "center"|Specific

|-

|align = "center"|C07K001456

|align = "center"|Peptides having more than 20 amino acids - IFN-alpha

|align = "center"|Specific

|-

|align = "center"|C07K014565

|align = "center"|Peptides having more than 20 amino acids - IFN-beta

|align = "center"|Specific

|-

|align = "center"|C07K001457

|align = "center"|Peptides having more than 20 amino acids - IFN-gamma

|align = "center"|Specific

|-

|align = "center"|C07K014715G

|align = "center"|Receptors; Cell surface antigens; Cell surface determinants - for interferons -

* '''Relevant US classes'''

|align = "center" bgcolor = "#99CCFF" colspan = "3"|'''US class'''

|-

|-

|align = "center"|4240854

|align = "center"|DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS - this subclass provides for patents which broadly claim interferon or a method of treatment of interferon where the classification of the interferon as alpha, beta or gamma interferon is impossible

|-

|align = "center"|4242811

|align = "center"| DRUG, BIO-AFFCTING AND BODY TREATING COMPOSITIONS - Virus (e.g., interferon-inducing virus, etc.)

|-

|align = "center"|42400141

|align = "center"|DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS - Attached to lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, or intercellular mediator specific for a hematopoietic cell (e.g., interferon, interleukin, macrophage factor, colony stimulating factor, erythropoietin); derivative thereof

|-

|align = "center"|514889

|align = "center"|DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS - INTERFERON INDUCER

|-

|align = "center"|530351

|align = "center"| CHEMISTRY: NATURAL RESINS OR DERIVATIVES; PEPTIDES OR PROTEINS; LIGNINS OR REACTION PRODUCTS THEREOF - Lymphokines, e.g., interferons, interlukins, etc.

|-

|align = "center"|930142

|align = "center"|PEPTIDE OR PROTEIN SEQUENCE - Interferon

|-

|align = "center"|4240851

|align = "center"|LYMPHOKINE - Included in this and the indented subclasses interferon, interleukin and macrophage factors (monokines)

|-

|align = "center"|4240855

|align = "center"|Gamma or immune: This subclass is indented under subclass 85.4. Subject matter in which the interferon is gamma or immune interferon.

|-

|align = "center"|4240856

|align = "center"|Subject matter in which the interferon is beta or fibroblast interferon.

|-

|align = "center"|4240857

|align = "center"|Subject matter in which the interferon is alpha or leukocyte interferon.